ICER Set to Evaluate Non-Drug Products in 2020

2020-01-14T09:19:17-05:00

The Boston-based Institute for Clinical and Economic Review (ICER) recently announced that in 2020, they are considering selecting two or more non-drug topics for assessment.

ICER Set to Evaluate Non-Drug Products in 20202020-01-14T09:19:17-05:00

Germany Paves the Way for Reimbursement of Digital Health Care Apps

2020-02-26T15:05:06-05:00

In Germany, doctors could potentially be prescribing health apps as medicines as early as 2020. This is one of the main objectives of the draft bill on the “Law for better provision through digitalization and innovation”, which is expected to be approved by the parliament early November.

Germany Paves the Way for Reimbursement of Digital Health Care Apps2020-02-26T15:05:06-05:00

First Meeting of the Italian Regional Purchasing Centers

2019-09-11T14:49:14-04:00

Quality is not anymore limited to the functional and esthetic products features and its handling use. The attention is now focused on the commercialization phase, innovative and efficacy features, profitability and usability of instruction for final users, as well as Eco-friendly features...

First Meeting of the Italian Regional Purchasing Centers2019-09-11T14:49:14-04:00

New Independent Medical Review Board for Germany

2019-09-11T14:49:42-04:00

For medical device and diagnostic innovators, a planned organizational change in review boards for Germany’s Statutory Health Insurance (SHI) could lead to new opportunities for market access of their products.

New Independent Medical Review Board for Germany2019-09-11T14:49:42-04:00

Winter Has Come – Aggressive National Programs To Drive Down Drug Costs

2019-09-11T14:48:29-04:00

China: 2018 was another eventful year for the pharmaceutical industry, highlighted by the Chinese government’s radical attempts to slash drug prices by the annual national drug price negotiation and along with the introduction of a national procurement program.

Winter Has Come – Aggressive National Programs To Drive Down Drug Costs2019-09-11T14:48:29-04:00

The Evolution of Medical Device Procurement in Italy

2019-09-11T15:21:31-04:00

Assobiomedica, the body representing the medical device sector in Italy, published an update to the report ‘Public Policies for the Purchase of Medical Devices’ in October 2018. Boston healthcare outline procurement trend in the Italian reimbursement environment.

The Evolution of Medical Device Procurement in Italy2019-09-11T15:21:31-04:00

Defining the value of innovative treatment methods in Germany

2019-09-11T15:22:46-04:00

A recent proposal by Jens Spahn, Federal Minister for Health in Germany, would limit the decision-making power of the Joint Federal Committee (G-BA) and lead to new evidence approaches for healthcare decision making.

Defining the value of innovative treatment methods in Germany2019-09-11T15:22:46-04:00